Search Site

Search form

Corporate Overview

Vertex is a global biotechnology company that aims to discover, develop and commercialize innovative medicines so people with serious diseases can lead better lives. In addition to our clinical development programs focused on cystic fibrosis, Vertex has more than a dozen ongoing research programs aimed at other serious and life-threatening diseases.

Learn more
NASDAQ: VRTX
$ 127.52
- 6.53%
4:00 PM on Aug 31, 2015  |  Delayed ~20 minutes.

Contact Investor Relations

Email: investorinfo@vrtx.com
Phone: 617-341-0585

More Information on Contacting Investor Relations

To receive Vertex's recent press releases by email please sign up for Email & News Alerts